Lyphochek 662
Lyphochek 662 is a benzodiazepine group IVD (FDA Class I; FDA product code LAS, Drug Specific Control Materials) made by Bio-Rad Laboratories, cleared under FDA 510(k) K910829 on 3 Apr 1991 and listed in FDA GUDID since 9 Jan 2017 (UDI-DI 00847661000587), active as of 23 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number00847661000587 | Date9 Jan 2017 | StatusListed |
| United States | FDA 510(k)SESE | NumberK910829 | Date3 Apr 1991 | StatusActive |
Official records
- AccessGUDID record 00847661000587
- FDA 510(k) database K910829
From the FDA record
- Device description
- Lyphochek Benzo/TCA Control- Set A Level 2 (A human serum assayed benzodiazepines and TCA control.)
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- FDA 510(k) K910829 decided 3 Apr 1991 Active
- FDA GUDID UDI-DI 00847661000587 listed 9 Jan 2017 Listed
Timeline
- Cleared FDA 510(k) K910829
- Listed FDA GUDID 00847661000587
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- Lyphochek
- Generic name
- Benzodiazepine group IVD, control
- Model / Ref / Catalog
- 662
- Primary DI / UDI-DI
- 00847661000587
- 510(k) Number
- FDA product code
- LAS
- GMDN term
- Benzodiazepine group IVD, control
- Device class
- Class I
- Regulation number
- 862.3280
- GUDID distribution status
- In Commercial Distribution
Similar devices
Other devices filed under FDA product code LAS (DRUG SPECIFIC CONTROL MATERIALS).
- QUANTIMETRIX NICOSURE COTININE URINE CONTROL by QUANTIMETRIX CORP.
- Emit II Plus Oxycodone Positive Control 100 10720810 9T619UL by Siemens Healthcare Diagnostics Inc.
- Plasma Control Bi-Level 0061 by Chromsystems Instruments & Chemicals GmbH
- EMIT-QUINIDINE CONTROL by Syva Co.
- EMIT QST TOBRAMYCIN CONTROL by Syva Co.
- Immunalysis 04Z42-10 by Immunalysis Corporation
- Immunalysis C309UR-5-2-1000 by Immunalysis Corporation
- ACS THERAPEUTIC DRUG MONIT CONTOLS, LEVEL I, II, III by Analytical Control Systems
- UTAK LABORATORIES TOXICOLOGY CONTROL by UTAK Laboratories Inc.
- Plasma Control Bi-Level 0224 by Chromsystems Instruments & Chemicals GmbH